A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule

被引:0
|
作者
H. J. L. M. Timmers
E. M. van Ginneken
P. Wesseling
C. G. J. Sweep
A. R. M. M. Hermus
机构
[1] Radboud University,Department of Endocrinology (741)
[2] Nijmegen Medical Center,Department of Pathology
[3] Radboud University,Department of Chemical Endocrinology
[4] Nijmegen Medical Center,undefined
[5] Radboud University,undefined
[6] Nijmegen Medical Center,undefined
来源
Journal of Endocrinological Investigation | 2006年 / 29卷
关键词
Cushing’s disease; pituitary adenoma; adrenal hyperplasia;
D O I
暂无
中图分类号
学科分类号
摘要
A 41-yr-old female was referred for signs and symptoms of Cushing’s syndrome. Cortisol was not suppressed by 1 mg dexamethasone (0.41 μmol/l). Midnight cortisol and ACTH were 0.44 μmol/l and 18 pmol/l, respectively. Urinary cortisol excretion was 250 nmol/24 h (normal between 30 and 150 nmol/24 h). A magnetic resonance imaging (MRI) revealed a pituitary lesion of 7 mm. ACTH and cortisol levels were unaltered by administration of human CRH and high-dose dexamethasone. Inferior sinus petrosus sampling showed CRH-stimulated ACTH levels of 128.4 (left sinus) vs a peripheral level of 19.2 pmol/l, indicating Cushing’s disease. After 4 months of pre-treatment with metyrapone and dexamethasone, endoscopic transsphenoidal resection of an ACTH-positive pituitary adenoma was performed. ACTH levels decreased to 2.6 pmol/l and fasting cortisol was 0.35 μmol/l. Despite clinical regression of Cushing’s syndrome and normalization of urinary cortisol, cortisol was not suppressed by 1 mg dexamethasone (0.30 μmol/l). Ten months post-operatively, signs and symptoms of Cushing’s syndrome reoccurred. A high dose dexamethasone test according to Liddle resulted in undetectable ACTH, but no suppression of cortisol levels, pointing towards adrenal-dependent Cushing’s syndrome. Computed tomography (CT)-scanning showed a left-sided adrenal macronodule. Laparoscopic left adrenalectomy revealed a cortical macronodule (3.5 cm) surrounded by micronodular hyperplasia. Fasting cortisol had decreased to 0.02 μmol/l. Glucocorticoid suppletion was started and tapered over 12 months. Symptoms and signs of hypercortisolism gradually disappeared. This case illustrates, that longstanding ACTH stimulation by a pituitary adenoma can induce unilateral macronodular adrenal hyperplasia with autonomous cortisol production.
引用
收藏
页码:934 / 939
页数:5
相关论文
共 32 条
  • [21] Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report
    Andrioli, Massimiliano
    Giraldi, Francesca Pecori
    Losa, Marco
    Terreni, Mariarosa
    Invitti, Cecilia
    Cavagnini, Francesco
    ENDOCRINE JOURNAL, 2010, 57 (09) : 833 - 837
  • [22] Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells
    Zhi Cai
    Bin Qian
    Jing Pang
    Zhou-bin Tan
    Kai Zhao
    Ting Lei
    Current Medical Science, 2022, 42 : 387 - 396
  • [23] Delayed postoperative hyponatremia followed by acute renal failure in a patient with an ACTH-secreting microadenoma of the pituitary
    Kristof, R. A.
    Klingmueller, D.
    Schramm, J.
    ZENTRALBLATT FUR NEUROCHIRURGIE, 2007, 68 (03): : 142 - 144
  • [24] Recurrences of ACTH-Secreting Adenomas After Pituitary Adenomectomy Can Be Accurately Predicted by Perioperative Measurements of Plasma ACTH Levels
    Abdelmannan, Dima
    Chaiban, Joumana
    Selman, Warren R.
    Arafah, Baha M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (04) : 1458 - 1465
  • [25] Bone morphogenetic protein 4 and bone morphogenetic protein receptor expression in the pituitary gland of adult dogs in healthy condition and with ACTH-secreting pituitary adenoma
    Sato, A.
    Ochi, H.
    Harada, Y.
    Yogo, T.
    Kanno, N.
    Hara, Y.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2017, 58 : 126 - 133
  • [26] Complication Rates after Endoscopic Transsphenoidal Surgery for ACTH-Secreting Pituitary Adenomas: A Comparative Analysis with GH and Nonfunctioning Adenomas
    Aibar-Duran, Juan A.
    Oladotun-Anka, Michael
    Asencio-Cortes, Carlos
    Valassi, Elena
    Webb, Susan
    Gras-Cabrerizo, Juan R.
    Monserrat-Gili, Joan
    Ribo, Pere Tresserras
    Munoz-Hernandez, Fernando
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2022, 83 : E274 - E283
  • [27] Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs
    Sato, Asaka
    Hara, Yasushi
    RESEARCH IN VETERINARY SCIENCE, 2018, 119 : 61 - 66
  • [28] Clinical management of critically ill patients with Cushing’s disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide
    S. Cannavo
    E. Messina
    A. Albani
    F. Ferrau
    V. Barresi
    S. Priola
    F. Esposito
    F. Angileri
    Endocrine, 2016, 52 : 481 - 487
  • [29] Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide
    Cannavo, S.
    Messina, E.
    Albani, A.
    Ferrau, F.
    Barresi, V.
    Priola, S.
    Esposito, F.
    Angileri, F.
    ENDOCRINE, 2016, 52 (03) : 481 - 487
  • [30] Lack of mutations in the gene coding for the hGR (NR3C1) in a pediatric patient with ACTH-secreting pituitary adenoma, absence of stigmata of Cushing's syndrome and unusual histologic features
    Briassoulis, George
    Horvath, Anelia
    Christoforou, Paola
    Lodish, Maya
    Xekouki, Paraskevi
    Quezado, Martha
    Patronas, Nicholas
    Keil, Meg F.
    Stratakis, Constantine A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (1-2) : 213 - 219